3-months Success Rate of Direct Pulp Capping With Biodentine®
CPDB
1 other identifier
observational
40
1 country
1
Brief Summary
Biodentine® is a most recent material for direct pulp capping. The aim of this study is to determine the 3 months success rate (defined as clinical and radiographic successes together) of direct pulp capping realized with Biodentine®.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 27, 2015
CompletedFirst Submitted
Initial submission to the registry
August 30, 2016
CompletedFirst Posted
Study publicly available on registry
September 8, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 2, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 2, 2016
CompletedNovember 29, 2017
November 1, 2017
1.5 years
August 30, 2016
November 28, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Treatment success
Treatment success will be asses only if clinical AND radiographic examination are successful
3 months after the dental direct pulp capping
Eligibility Criteria
adult patients with a small pulp exposure (\<2mm) created during carie removal on a vital tooth
You may qualify if:
- adult patients with a small pulp exposure (\<2mm) created during decy removal on a vital tooth
- absence of spontaneous pain, of fistula, of swelling, of mobility, of periodontal enlargement, of resorption, of periapical pathosis, of furcation defect, on this tooth
- normal periodontal probing around this tooth
- cold vitality test : positive but non increased on this tooth
You may not qualify if:
- patient with at risk of endocarditis,
- patient with allergic reactions to a product used in the protocol,
- patient with a lack of oral hygiene,
- tooth with spontaneous pain, fistula, swelling, increased mobility, periodontal enlargement, resorption, periapical pathosis, furcation defect, pulpal necrosis, pulpal irreversible inflammation, excessive dental destruction, very abundant pulp bleeding, impossible set-up of the rubber dam
- tooth with a pulp exposure \>2mm
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chevalier
Brest, 29200, France
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 30, 2016
First Posted
September 8, 2016
Study Start
May 27, 2015
Primary Completion
December 2, 2016
Study Completion
December 2, 2016
Last Updated
November 29, 2017
Record last verified: 2017-11